(Q46819265)

25 December 2017

title

Effects of 5-aza-2'-deoxycytidine on proliferation, differentiation and p15/INK4b regulation of human hematopoietic progenitor cells (English)

1 reference

25 December 2017

author name string

Y Guo

1

1 reference

25 December 2017

M Engelhardt

2

1 reference

25 December 2017

D Wider

3

1 reference

25 December 2017

M Abdelkarim

4

1 reference

25 December 2017

M Lübbert

5

1 reference

25 December 2017

language of work or name

1 reference

1 January 2006

1 reference

25 December 2017

published in

Leukemia

1 reference

25 December 2017

volume

20

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

115-121

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404019

exact match

0 references

cites work

Role of epigenetic changes in hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Multiple new phenotypes induced in and 3T3 cells treated with 5-azacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Effect of 5-aza-2'-deoxycytidine and vitamin D3 analogs on growth and differentiation of human myeloid leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Production of stem-cell transplants according to good manufacturing practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Side-population cells from different precursor compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Expression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2'-deoxycytidine (decitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

The human lysozyme gene undergoes stepwise demethylation during phagocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

7 January 2021

Increased Methylation of the <i>c-fms</i>Protooncogene in Acute Myelomonocytic Leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

7 January 2021

Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

7 January 2021

Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

7 January 2021

Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

7 January 2021

Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404019

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404019

1 reference

25 December 2017

PubMed ID

16307025

1 reference

25 December 2017